Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Johnson & Johnson Announces Major Commitment of Up to $200 Million
Friday, October 31, 2014
Commitment to speed Ebola vaccine development and significantly expand production.

Argos Breaks Ground on Biomanufacturing Facility in Research Triangle Park Area
Thursday, October 30, 2014
New 100,000 square foot facility supported by incentives from State of North Carolina, Durham County, City of Durham and North Carolina Biotechnology Center.

Gallus and GE Healthcare Win Global Bioprocessing Industry Award
Thursday, October 30, 2014
Advanced single-use biomanufacturing facility designed and built in just nine months.

AB SCIEX Wins New Product Innovation Award in Asia Pacific
Thursday, October 30, 2014
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.

Improved Mouse Model will Accelerate Research on Potential Ebola Vaccines, Treatments
Thursday, October 30, 2014
UNC researchers and colleagues are the first to develop a mouse model that more accurately reflects human disease symptoms; they found a single gene crucial for disease severity.

Team Discovers How Microbes Build a Powerful Antibiotic
Wednesday, October 29, 2014
Researchers discovery opens up new avenues of research into thousands of similar molecules.

Bavarian Nordic Enters Licensing and Supply Agreement with Janssen
Tuesday, October 28, 2014
Bavarian Nordic will scale up and is targeting to manufacture more than 1 million doses of the prophylactic vaccine in 2015 for clinical trials and emergency use in the current Ebola outbreak in West Africa.

BioSilta Establishes Cambridgeshire HQ
Tuesday, October 28, 2014
BioSilta Ltd has completed the set-up of operational and commercial headquarters in St Ives, Cambridgeshire, UK.

CSL to Acquire Novartis Influenza Vaccine Business
Monday, October 27, 2014
CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 1224
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters